Poonam Vohra

979 total citations
56 papers, 545 citations indexed

About

Poonam Vohra is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Poonam Vohra has authored 56 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Poonam Vohra's work include Urinary and Genital Oncology Studies (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer and Skin Lesions (7 papers). Poonam Vohra is often cited by papers focused on Urinary and Genital Oncology Studies (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer and Skin Lesions (7 papers). Poonam Vohra collaborates with scholars based in United States, India and United Kingdom. Poonam Vohra's co-authors include Yunn‐Yi Chen, Gregor Krings, Charles Zaloudek, Joseph T. Rabban, Britt‐Marie Ljung, Di Lü, Kenneth L. Rock, Bruce A. Woda, Zhong Jiang and Tarık Tihan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Microbiology Reviews.

In The Last Decade

Poonam Vohra

47 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Poonam Vohra United States 13 181 162 160 129 113 56 545
Jula Veerapong United States 12 211 1.2× 61 0.4× 165 1.0× 120 0.9× 95 0.8× 45 513
H. Jouhadi Morocco 12 215 1.2× 70 0.4× 94 0.6× 89 0.7× 83 0.7× 92 472
R Chin United States 12 314 1.7× 187 1.2× 180 1.1× 47 0.4× 161 1.4× 40 679
Srinivas Mandavilli United States 14 289 1.6× 220 1.4× 213 1.3× 176 1.4× 104 0.9× 30 757
F. Mayall United Kingdom 16 212 1.2× 363 2.2× 124 0.8× 142 1.1× 80 0.7× 39 693
Heran Deng China 13 262 1.4× 91 0.6× 81 0.5× 81 0.6× 216 1.9× 31 577
Kathrin Glatz Switzerland 8 336 1.9× 118 0.7× 128 0.8× 55 0.4× 50 0.4× 12 581
Patricia C. Ewing‐Graham Netherlands 13 137 0.8× 74 0.5× 192 1.2× 43 0.3× 86 0.8× 39 528
Amir Momeni Boroujeni United States 14 154 0.9× 185 1.1× 95 0.6× 104 0.8× 109 1.0× 53 633
Pamela Sighinolfi Italy 11 166 0.9× 65 0.4× 70 0.4× 52 0.4× 83 0.7× 14 386

Countries citing papers authored by Poonam Vohra

Since Specialization
Citations

This map shows the geographic impact of Poonam Vohra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Poonam Vohra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Poonam Vohra more than expected).

Fields of papers citing papers by Poonam Vohra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Poonam Vohra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Poonam Vohra. The network helps show where Poonam Vohra may publish in the future.

Co-authorship network of co-authors of Poonam Vohra

This figure shows the co-authorship network connecting the top 25 collaborators of Poonam Vohra. A scholar is included among the top collaborators of Poonam Vohra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Poonam Vohra. Poonam Vohra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vohra, Poonam, Mark M. Moasser, Shoko Abe, et al.. (2025). FNA biopsy of breast specimens effectively harvests cells for patient‐derived organoids modeling ductal carcinoma in situ. Cancer Cytopathology. 133(11). e70052–e70052.
2.
Wu, Maoxin, et al.. (2025). American Society of Cytopathology (ASC) study group recommendations for practicing ultrasound guided-fine needle aspiration (US-FNA). Journal of the American Society of Cytopathology. 14(6). 384–394.
3.
Tchou, Julia, Sara J. Venters, Ronald Balassanian, et al.. (2024). Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer. Annals of Surgical Oncology. 31(12). 8093–8101. 1 indexed citations
4.
Balassanian, Ronald, et al.. (2024). Cytopathology in the era of social media. Diagnostic Cytopathology. 52(8). 448–459. 1 indexed citations
5.
Thomas, Alexandra, Denise M. Wolf, Ronald Balassanian, et al.. (2024). Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.. Journal of Clinical Oncology. 42(23_suppl). 1–1. 1 indexed citations
6.
Balassanian, Ronald, et al.. (2024). Fine needle aspiration biopsy in low‐ and middle‐income countries. Diagnostic Cytopathology. 52(8). 426–432. 2 indexed citations
7.
Ng, Dianna, Edda Vuhahula, Godfrey Sama Philipo, et al.. (2024). Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study. The Lancet Oncology. 25(11). 1440–1452.
9.
Shamir, Eliah R., Gregory R. Bean, Christopher J. Schwartz, et al.. (2023). Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression. Modern Pathology. 36(12). 100324–100324. 6 indexed citations
10.
Greenland, Nancy, et al.. (2023). Utility and performance of cell blocks in urine cytology: Experience at three teaching hospitals. Cancer Cytopathology. 131(10). 614–625. 3 indexed citations
11.
Ding, Chien‐Kuang Cornelia, et al.. (2023). Urine cytology in patients with gender confirmation surgery and hormone therapy: evaluation of urine cytology performance in an underserved patient population. Journal of the American Society of Cytopathology. 12(4). 267–274.
12.
Kurtycz, Daniel, et al.. (2023). American Society of Cytopathology Survey on Pathologist Performed Ultrasound Guided Fine Needle Aspiration. Journal of the American Society of Cytopathology. 12(5). S45–S45.
13.
Greenland, Nancy, et al.. (2022). Utility and Performance of Cell Blocks in Urine Cytology: Experience at Three Teaching Hospitals. Journal of the American Society of Cytopathology. 11(6). S10–S10. 1 indexed citations
14.
George, Ashley F., Xiaoyu Luo, Jason Neidleman, et al.. (2022). Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals. Frontiers in Immunology. 13. 803417–803417. 10 indexed citations
15.
Goodwin, Karen, et al.. (2021). Cystic Neutrophilic Granulomatous Mastitis Regression with the Tumor Necrosis Factor-α Inhibitor, Adalimumab. SHILAP Revista de lepidopterología. 18(1). 94–101. 17 indexed citations
16.
Beça, Francisco, Gregor Krings, Yunn‐Yi Chen, et al.. (2020). Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Modern Pathology. 33(8). 1518–1526. 19 indexed citations
17.
Grenert, James P., et al.. (2017). Concomitant Epstein-Barr Virus-associated smooth muscle tumor and granulomatous inflammation of the liver. Pathology - Research and Practice. 213(10). 1306–1309. 5 indexed citations
19.
Krings, Gregor, et al.. (2014). Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Human Pathology. 45(11). 2225–2232. 72 indexed citations
20.
Vohra, Poonam, et al.. (2011). Paget's disease of the breast masquerading as squamous cell carcinoma on cytology: A case report. Diagnostic Cytopathology. 40(11). 1015–1018. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026